In this context, restoration of synaptic composition through enhanced neuronal activity proved neuroprotective not only in ALS (Saxena et al., 2013; Ba̧czyk et al., 2020; Catanese et al., 2021), but also in SMA (Simon et al., 2021). The gene discussed is SMN1; the disease is amyotrophic lateral sclerosis.